4.7 Article

In vitro and in vivo activities of imipenem combined with BLI-489 against class D β-lactamase-producing Acinetobacter baumannii

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 76, 期 2, 页码 451-459

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkaa421

关键词

-

资金

  1. Taipei Veterans General Hospital [V107C-037, V108C-012, VTA107-T-3-2, VTA108-T-2-3, VTA109-T-3-2]
  2. Tri-Service General Hospital [TSGH-C107-099, TSGH-E-109237, VTA109-T-3-1]
  3. Ministry of Science and Technology [MOST 107-2314-B075-066-MY3, MOST 108-2314-B-016-029]

向作者/读者索取更多资源

The combination of imipenem and BLI-489 showed synergistic effects against CRAb isolates producing CHDLs, particularly OXA-24, OXA-51, and OXA-58. The results demonstrated significant inhibition and rescue effects on CRAb-infected experimental animals.
Background: According to our preliminary study, BLI-489 has the potential to inhibit the hydrolysing activity of OXA-51-like beta-lactamase produced by carbapenem-resistant Acinetobacter baumannii (CRAb). Objectives: In the present study, the in vitro and in vivo activities of imipenem combined with BLI-489 against CRAb producing carbapenem-hydrolysing class D beta-lactamases (CHDLs), namely OXA-23, OXA-24, OXA-51 and OXA-58, were determined. Methods: A chequerboard analysis of imipenem and BLI-489 was performed using 57 and 7 clinical CRAb isolates producing different CHDLs and MBLs, respectively. Four representative strains harbouring different CHDL genes were subjected to a time-kill assay to evaluate the synergistic effects. An in silico docking analysis was conducted to simulate the interactions between BLI-489 and the different families of CHDLs. The in vivo activities of this combination were assessed using a Caenorhabditis elegans survival assay and a mouse pneumonia model. Results: Chequerboard analysis showed that imipenem and BLI-489 had a synergistic effect on 14.3, 92.9, 100, 16.7 and 100% of MBL-, OXA-23-, OXA-24-like-, OXA-51-like- and OXA-58-producing CRAb isolates, respectively. In the time-kill assay, imipenem and BLI-489 showed synergy against OXA-24-like-, OXA-51-like- and OXA-58-, but not OXA-23-producing CRAb isolates after 24 h. The in silico docking analysis showed that BLI-489 could bind to the active sites of OXA-24 and OXA-58 to confer strong inhibition activity. The combination of imipenem and BLI-489 exhibited synergistic effects for the rescue of CRAb-infected C. elegans and mice. Conclusions: Imipenem combined with BLI-489 has synergistic effects against CHDL-producing CRAb isolates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据